|
2019
|
P/S
|
Printed matter, namely, promotional and informational materials in the nature of brochures, bookl... |
|
2015
|
P/S
|
Pharmaceutical preparations for human use, namely, an anticoagulant for the prevention and treatm... |
|
2009
|
Invention
|
Substituted lactams as inhibitors of a beta protein production.
This invention relates to novel ... |
|
|
Invention
|
Substituted lactams as inhibitors of abeta protein production.
This invention relates to novel l... |
|
|
Invention
|
Cyclic malonamides as inhibitors of abeta protein production.
This invention relates to novel cy... |
|
|
Invention
|
Substituted lactams as inhibitors of aβ protein production. This invention relates to novel lacta... |
|
|
Invention
|
Identification of predictive markers of response to dasatinib in human colon cancer. Methods and ... |
|
2008
|
Invention
|
Lactams substituted by cyclic succinates as inhibitors of abeta protein production.
This inventi... |
|
|
Invention
|
Succinoylamino benzodiazepines as inhibitors of ab protein production.
This invention relates to... |
|
|
Invention
|
Hydroxyalkanoylaminolactams and related structures as inhibitors of a beta protein production.
T... |
|
|
Invention
|
Cyclic malonamides as inhibitors of aβ protein production. This invention relates to novel cyclic... |
|
|
Invention
|
Succinoylamino benzodiazepines as inhibitors of aβ protein production. This invention relates to ... |
|
|
Invention
|
Succinoylamino benzodiazepines as inhibitors of abeta protein production.
This invention relates... |
|
|
Invention
|
4-(2-butylamino)-2,7-dimethyl-8-(2-methyl-6-methoxypyrid-3-yl)pyrazolo-[1,5-a]-1,3,5-triazine, it... |
|
|
Invention
|
Hydroxyalkanoylaminolactams and related structures as inhibitors of aβ protein production. This i... |
|
2007
|
Invention
|
Radioactive ligands for cardiac beta1 adrenoreceptor for imaging congestive heart failure. Novel ... |
|
|
Invention
|
Preparation of paramagnetic nanoparticles conjugated to leukotriene b4 (ltb4) receptor antagonist... |
|
|
Invention
|
Succinoylamino lactams as inhibitors of a-β protein production. This invention relates to novel l... |
|
|
Invention
|
Substituted lactams as inhibitors of aβ protein production. This invention relates to novel lact... |
|
|
Invention
|
Assays and peptide substrate for determining aggrecan degrading metallo protease activity.
This ... |
|
|
Invention
|
Process for the preparation of pyrazolo[1,5-a]-1,3,5-triazines and intermediates thereof. The pre... |
|
|
Invention
|
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands. Com... |
|
2006
|
Invention
|
Contrast agents for myocardium perfusion imaging. The present invention is directed, in part, to ... |
|
|
Invention
|
Moesin, caveolin 1 and yes associated protein 1 as predictive markers of response to dasatinib in... |
|
|
Invention
|
T315a and f317i mutations of bcr-abl kinase domain. The present invention relates to mutant BCR-A... |
|
|
Invention
|
Methods of making radiolabeled tracers and precursors thereof. The present disclosure relates to ... |
|
|
Invention
|
Succinoylamino lactams as inhibitors of aβ protein production. This invention relates to novel la... |
|
|
Invention
|
Azolo triazines and pyrimidines. Corticotropin releasing factor (CRF) antagonists of formula I or... |
|
|
Invention
|
Hydrazide conjugates as imaging agents. The present disclosure is directed to diagnostic agents. ... |
|
|
Invention
|
Substituted heterocycle fused gamma-carbolines. The present invention is directed to compounds us... |
|
|
Invention
|
Substituted heterocycle fused γ-carbolines. The present invention is directed to compounds useful... |
|
|
Invention
|
Substituted heterocycle fused gamma-carbolines. 9, X, b, k, m, and n, and the dashed lines are de... |
|
|
Invention
|
Substituted lactams as inhibitors of abeta protein production.
This invention relates to novel ... |
|
|
Invention
|
Treatment of disease with antibodies against high molecular weight kininogen domain 5. Antibodies... |
|
|
Invention
|
Cyclic malonamides as inhibitors of aβ protein protection. This invention relates to novel cyclic... |
|
2005
|
Invention
|
Compounds for myocardial perfusion imaging. The present disclosure is directed to compounds compr... |
|
|
Invention
|
Succinoylaminobenzodiazepines as inhibitors of aβ protein production. This invention relates to n... |
|
|
Invention
|
Piperizinones as modulators of chemokine receptor activity. The present application describes mod... |
|
|
Invention
|
Diamines as modulators of chemokine receptor activity. The present application describes modulato... |
|
|
Invention
|
Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-prolifera... |
|
2004
|
Invention
|
Lactams substituted by cyclic succinates as inhibitors of aβ protein production. This invention r... |
|
|
Invention
|
Heterocyclic piperidines as modulators of chemokine receptor activity. The present application de... |
|
2002
|
Invention
|
Inhibition of angiogenesis by antibodies against high molecular weight kininogen domain 5. Antibo... |
|
2000
|
P/S
|
Booklet and health journal (calendar). Enrollment in a patient support program which involves rec... |
|
1998
|
P/S
|
Pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system ... |
|
|
P/S
|
Pharmaceutical preparations, for the treatment of cardiovascular diseases, central nervous system... |
|
1997
|
P/S
|
Pharmaceutical preparations used for the treatment of infectious diseases. |
|
|
P/S
|
pharmaceutical products, other than vaccines, for the treatment of HIV/AIDS |
|
1980
|
P/S
|
Plasma volume expander. |
|
1964
|
P/S
|
Antiviral agent. |
|
1957
|
P/S
|
A medicinal preparation namely, an anticoagulant.
A hemorrhagic producing drug. |
|
1950
|
P/S
|
Medicinal and pharmaceutical preparation, specifically an analgesic. |
|
1945
|
P/S
|
A narcotic preparation used as an analgesic and antitussive. |
